Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.18 | N/A |
| PEG Ratio (TTM) | -0.48 | N/A |
| P/S Ratio (TTM) | 0.39 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 5.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 430.70 | N/A |
| Price to 5YR AVG FCF Ratio | 5.49 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.01% | N/A |
| ROE (TTM) | 3.99% | N/A |
| Net Profit Margin (TTM) | 1.39% | N/A |
| ROIC 5YR AVG | 21.31% | N/A |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 349.20% | -190.34% | 1,356.16% |
| Revenue | -2.93% | -6.62% | 3.90% |
| Net Income | 142.90% | -178.49% | 113.92% |
| Cash Flow | 1.45% | 18.00% | 21.13% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.22 | N/A |
| Quick Ratio (TTM) | 0.94 | N/A |
| D/E Ratio (TTM) | 0.89 | N/A |
| Interest Coverage (TTM) | 5.24 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.19 | N/A |
| LTL to 5YR AVG FCF | 4.11 | N/A |
| Shares Outstanding Growth 5YR AVG | 83.65% | N/A |